19 / 25
46,XY DSD: Algemeen
17
Literatuurlijst
1.
Ahmed SF, Achermann JC, Arlt W, Balen AH, Conway G, Edwards Z, et al. UK guidance on the initial evaluation of an infant or an
adolescent with a suspected disorder of sex development. Clin Endocrinol. 2011. 75: 12-26.
2.
Amaral RC, Inacio M, Brito VN, Bachega TA, Domenice S, Arnhold IJP, Madureira G, et al. Quality of life of patients with 46,XX and
46,XY disorders of sex development. Clin Endocrinol. 2015. 82: 159-164.
3.
Berra M, Liao LM, Creighton SM, Conway GS. Long-term health issues in women with XY karyotype. Maturitas. 2010. 65: 172-178.
4.
Boehmer AML, Brinkmann AO, Sandkuijl LA, Halley DJJ, Niermeijer MF, Andersson S, et al. 17
β
-Hydroxysteroid Dehydrogenase-3
Deficiency: Diagnosis, Phenotypic Variability, Population Genetics, andWorldwide Distribution of Ancient and de Novo Mutations.
J Clin Endocrinol Metab. 1999. 84. 12:4713-4721.
5.
Buiting C, Njoo K. Richtlijn Informatie-uitwisseling tussen Huisarts en Specialist bij verwijzingen (HASP). 2008 Nederlands
Huisartsen Genootschap.
https://www.nhg.org/themas/artikelen/richtlijn-informatie-uitwisseling-tussen-huisarts-en- specialist-bij-verwijzingen .6.
Callens N, Van der Zwan YG, Drop SLS, Cools M, Beerendonk CM, Wolffenbuttel KP, et al. Do surgical interventions influence
psychosexual and cosmetic outcomes in women with DSD? ISRN Endocrinol. 2012; 2012: 276742.
7.
Eijssens EC. Rapport ’Spierziekten als zeldzame ziekten in de huisartsenpraktijk’. 2006.
8.
Hendriks S. Generieke zorgthema Huisartsgeneeskundige zorg. 2014.
www.zorgstandaarden.net/nl/wat-is-een-zeldzame- aandoening/generieke-zorgthemas .9.
Hewitt JK, Warne GL. Management of Disorders of Sex Development. Pediatric Health. 2009 (3)1, 51-65.
10. Hughes IA, Werner R, et al. “Androgen insensitivity syndrome.” Semin Reprod Med. 2012. 30: 432-442.
11. Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. Arch Dis Child. 2006. 91; 554-
562.
12. Kim KS, Kim J. Disorders of Sex development. Korean J Urol. 2012 Jan; 53: 1-8.
13. Lee PA, Nordentröm A, Houk CP, Ahmed SF, Auchus R, Baratz A, et al. Global Disorders of Sex Development Update since 2006:
Perceptions, approach and care. Horm Res Paediatr. 2016. 85: 158-180.
14. Mendonca BB, Domenice S, Arnhold IJP, Costa EMF. “46,XY disorders of sex development (DSD).” Clin Endocrinol. 2009. 70: 173-187.
15. Slijper FME, Drop SLS, Molenaar JC, Scholtmeijer RJ. Pasgeborene met gestoorde geslachtsontwikkeling die de vrouwelijke sekse
toegewezen krijgen; advisering van de ouders. Ned Tijdschr Geneeskd. 1988. 132: 1892-1896.
16. Wisniewski, AB. “Gender Development in 46,XY DSD: Influences of Chromosomes, Hormones, and Interactions with Parents and
Healthcare Professionals.” Scientifica (Cairo) 2012: 834967.
17. Wisniewski AB, Mazur T. 46,XY DSD with Female or Ambiguous External Genitalia at Birth due to Androgen Insensitivity Syndrome,
5alpha-Reductase-2 Deficiency, or 17beta-Hydroxysteroid Dehydrogenase Deficiency: A Review of Quality of Life Outcomes. Int J
Pediatr Endocrinol. 2009. Doi: 10115/2009567430.
18. Erfocentrum.
www.erfelijkheid.nl/ziektes/androgeen-ongevoeligheids-syndroom.19. Genetics Home Reference. Leydig cell hypoplasia. Available from:
http://ghr.nlm.nih.gov/condition/leydig-cell-hypoplasia.